Mediastinal Air After Methamphetamine Inhalation: What CT and a Negative Esophagogram Actually Established

Written by

in

A positive drug screen, an abnormal chest scan and a negative contrast-swallow study are not interchangeable evidence. Each addresses a different question. A historical 2024 case of pneumomediastinum after reported methamphetamine vapor inhalation shows why the final account should preserve those distinctions.

What happened in the reported patient?

Shahnazi and colleagues described a 25-year-old man with a history of polysubstance use who presented after a reported nine-day methamphetamine binge. He developed worsening chest pain and breathlessness. Examination identified palpable crepitation around the neck and right upper back, and radiography showed soft-tissue and mediastinal air.

Computed tomography demonstrated a moderate volume of mediastinal air extending toward the lower neck and right chest wall. It did not show pleural separation suggesting pneumothorax. Repeated vomiting before admission raised concern for an esophageal rupture, so a Gastrografin esophagogram was performed on day two. No contrast leak was demonstrated. Symptoms improved without surgery, and discharge occurred on day three.

Why separate pneumomediastinum from pneumothorax?

The location of air is central to the finding. Air in the mediastinum and surrounding soft tissues does not automatically establish air in the pleural space. The CT description is therefore more informative than a broad statement that the patient had a drug-related “collapsed lung.”

This also illustrates how to handle inconsistent wording within a paper. Although the introduction refers to pneumothorax as well as pneumomediastinum, the detailed case description expressly reports no CT evidence of pleural separation. An evidence-based summary should follow the actual reported imaging rather than silently add a second diagnosis.

What did the negative esophagogram mean?

It addressed a plausible competing explanation prompted by the vomiting history. The authors interpreted the negative study as excluding Boerhaave’s syndrome in their clinical assessment. The measured observation was that contrast leakage was not demonstrated in this patient at that examination.

That distinction prevents two opposite errors. The absence of demonstrated leakage should not disappear from the account, because it affected the authors’ interpretation. But it should not become a general rule that every future patient with vomiting and mediastinal air has no esophageal injury. A single case cannot validate a diagnostic pathway or establish a test’s sensitivity.

Did toxicology identify the cause of the air leak?

The report describes a positive urine methamphetamine screen and an inhalation history. It supplies no quantified methamphetamine concentration or controlled dose. A urine result documents a toxicological finding; it does not show the physical sequence that produced mediastinal air.

Pressure changes during inhalation and vomiting are mechanistic possibilities discussed in the report. Their individual contributions were not measured. The history of polysubstance use also belongs in the interpretation rather than being removed to create an apparently isolated methamphetamine exposure.

What can this case contribute to a forensic review?

The strongest contribution is the sequence of objective observations: soft-tissue crepitation, radiographic air, CT localization and a contrast study without a demonstrated leak. Improvement without surgery describes this patient’s course. It does not prove that similar presentations are benign, quantify complication rates, or establish a concentration threshold for lung injury.

For a case-based opinion, separate the confirmed anatomical finding, the reported exposure and the proposed mechanism. That structure preserves the report’s clinical value while avoiding a causal conclusion stronger than the evidence.

Source

Shahnazi A, Bayrakdar K, Cortorreal P, Burmaster K, Junko G. A 25-Year-Old Man with a History of Substance Abuse Presenting with Pneumomediastinum Due to Methamphetamine Vapor Inhalation. American Journal of Case Reports. 2024;25:e941509. DOI: 10.12659/AJCR.941509. Publisher full text; PMC full text.